AccuStem Sciences, Inc. (ACUT)
OTCMKTS
· Delayed Price · Currency is USD
1.020
+0.010 (0.99%)
At close: Jun 17, 2025
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $16.39 million as of June 17, 2025. Its market cap has increased by 99.01% in one year.
Market Cap
16.39M
Enterprise Value
16.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.01
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 16.39M, a decrease of -19.71%. That is a compound annual growth rate of -6.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 16.23M | 219.34% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Veradigm | 764.23M |
| Elite Pharmaceuticals | 717.88M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| CytoDyn | 441.29M |
| Northwest Biotherapeutics | 403.72M |
| Glass House Brands | 384.13M |